Cargando…

Prostate-specific Membrane Antigen Positron Emission Tomography, Not Conventional Imaging, Should Be Performed for Primary Staging of High-risk Prostate Cancer

Detalles Bibliográficos
Autores principales:	Ceci, Francesco, Musi, Gennaro, De Cobelli, Ottavio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Open to Debate For
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572873/ https://www.ncbi.nlm.nih.gov/pubmed/34766033 http://dx.doi.org/10.1016/j.euros.2021.08.012

Ejemplares similares

Prostate-specific Membrane Antigen Positron Emission Tomography, Not Conventional Imaging, Should Be Performed for Primary Staging of High-risk Prostate Cancer: Con
por: van der Poel, Henk
Publicado: (2021)

Accuracy Versus Impact: The Referee Verdict on Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography for Staging of Prostate Cancer
por: O'Brien, Jonathan, et al.
Publicado: (2021)

TREXIT Is Now: Should We Abandon the Transrectal Route for Prostate Biopsy? Yes
por: Grummet, Jeremy P., et al.
Publicado: (2021)

Retroperitoneal Lymph Node Dissection Should Be a Standard-of-Care Treatment Option For Stage II Seminoma
por: Alsyouf, Muhannad, et al.
Publicado: (2023)

Prostate Cancer: Is There Still a Role for Systematic Biopsies? Yes
por: Gandaglia, Giorgio, et al.
Publicado: (2022)

Radiotherapy is the Preferred Primary Tumor Treatment in Oligometastatic Prostate Cancer
por: van Moorselaar, R. Jeroen A., et al.
Publicado: (2022)

High-risk Locally Advanced Prostate Cancer: Multimodal Treatment Is the Key
por: Terlizzi, Mario, et al.
Publicado: (2022)

How To Manage T3b Prostate Cancer in the Contemporary Era: Is Radiotherapy the Standard of Care?
por: Achard, Vérane, et al.
Publicado: (2023)

Stage II Seminoma: Why Chemotherapy Should Remain a Standard
por: Naoun, Natacha, et al.
Publicado: (2023)

Hormonal Intensification Should Start at the Low-risk Stage in Metastatic Prostate Cancer
por: Jazayeri, Seyed Behzad, et al.
Publicado: (2022)

Making the Case for Prostate-Specific Membrane Antigen-Targeted Positron Emission Tomography/Computed Tomography in Suspected Prostate Cancer
por: Singh, Harmandeep
Publicado: (2020)

Thulium YAG is the Best Laser for the Prostate Because of Versatility
por: Herrmann, Thomas R.W., et al.
Publicado: (2022)

Which is the Best Laser for Treatment of Benign Prostatic Hyperplasia?
por: Scoffone, Cesare Marco, et al.
Publicado: (2022)

Dual-Tracer Positron-Emission Tomography Using Prostate-Specific Membrane Antigen and Fluorodeoxyglucose for Staging of Prostate Cancer: A Systematic Review
por: McGeorge, Stephen, et al.
Publicado: (2021)

Current status of radioligand therapy and positron-emission tomography with prostate-specific membrane antigen
por: Inubushi, Masayuki, et al.
Publicado: (2020)

Initial risk stratification and staging in prostate cancer with prostatic-specific membrane antigen positron emission tomography/computed tomography: A first-stop-shop
por: Gupta, Manoj, et al.
Publicado: (2018)

There Is No Longer a Role for Systematic Biopsies in Prostate Cancer Diagnosis
por: Kasivisvanathan, Veeru, et al.
Publicado: (2022)

Prostate-specific membrane antigen (PSMA)–ligand positron emission tomography and radioligand therapy (RLT) of prostate cancer
por: Tateishi, Ukihide
Publicado: (2020)

Online Prostate-Specific Membrane Antigen and Positron Emission Tomography–Guided Radiation Therapy for Oligometastatic Prostate Cancer
por: Hrinivich, William T., et al.
Publicado: (2019)

Metastatic superscan in prostate carcinoma on gallium-68-prostate-specific membrane antigen positron emission tomography/computed tomography scan
por: Agarwal, Krishan Kant, et al.
Publicado: (2016)

Upcoming Role of Prostate Specific Membrane Antigen Positron Emission Tomography-Computed Tomography in Detecting Occult Metastases in Prostate Cancer
por: Gupta, Parul, et al.
Publicado: (2019)

Oligometastasis to testis in prostate cancer: Role of gallium-68 prostate-specific membrane antigen positron-emission tomography computed tomography
por: Gupta, Manoj, et al.
Publicado: (2020)

Clinically Significant Prostate Cancer Diagnosis Without Histological Proof: A Possibility in the Prostate-specific Membrane Antigen Era?
por: Heetman, Joris G., et al.
Publicado: (2022)

Primary Tumor Treatment in Oligometastatic Prostate Cancer: Radiotherapy Versus Radical Prostatectomy
por: Knipper, Sophie, et al.
Publicado: (2022)

Primary Tumour Treatment in Oligometastatic Prostate Cancer: Radiotherapy Versus Radical Prostatectomy
por: Ting, Francis, et al.
Publicado: (2022)

How To Manage T3b Prostate Cancer in the Contemporary Era: Referee Position
por: Bossi, Alberto, et al.
Publicado: (2023)

How To Manage T3b Prostate Cancer in the Contemporary Era: The Benefits of Surgery
por: Peyrottes, Arthur, et al.
Publicado: (2023)

Prostate-specific membrane antigen positron emission tomography (PSMA-PET) for local staging of prostate cancer: a systematic review and meta-analysis
por: Woo, Sungmin, et al.
Publicado: (2020)

Cost-Effectiveness Analysis of Prostate-Specific Membrane Antigen (PSMA) Positron Emission Tomography/Computed Tomography (PET/CT) for the Primary Staging of Prostate Cancer in Australia
por: Song, Rachel, et al.
Publicado: (2022)

Effect of prostate-specific membrane antigen positron emission tomography on the decision-making of radiation oncologists
por: Shakespeare, Thomas P.
Publicado: (2015)

Defining Prostatic Vascular Pedicle Recurrence and the Anatomy of Local Recurrence of Prostate Cancer on Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography
por: Dundee, Philip, et al.
Publicado: (2022)

Gallium-68 prostate-specific membrane antigen positron emission tomography/computed tomography compared with diagnostic computed tomography in relapsed prostate cancer
por: Asokendaran, Marcus Edward, et al.
Publicado: (2019)

Risk of Tumor Upstaging With Prostate-Specific Membrane Antigen Positron Emission Tomography in Patients With High-Risk Prostate Cancer
por: Brant, Aaron, et al.
Publicado: (2022)

Spinal Tuberculosis Mimicking as Prostate Cancer Metastases in Ga-68 Prostate-specific Membrane Antigen Positron-emission Tomography/Computed Tomography
por: Gupta, Nitin, et al.
Publicado: (2020)

Solitary Metastasis of Prostatic Adenocarcinoma to the Testicle Detected by (68)Ga-Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography
por: Deeb, Ibrahim Alsheikh, et al.
Publicado: (2020)

Solitary Penile Metastasis from Prostate Cancer on (18)F-Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography
por: Dhull, Varun Singh, et al.
Publicado: (2022)

Comparison of (68)Ga-labeled Prostate-specific Membrane Antigen Ligand Positron Emission Tomography/Magnetic Resonance Imaging and Positron Emission Tomography/Computed Tomography for Primary Staging of Prostate Cancer: A Systematic Review and Meta-analysis
por: Ling, Sui Wai, et al.
Publicado: (2021)

(68)Ga-Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography: How Much Specific It Is?
por: Sahoo, Manas Kumar
Publicado: (2017)

Fluorodeoxyglucose, sodium fluoride, and prostate-specific membrane antigen positron emission tomography studies for treatment response assessment in prostate cancer
por: Sarikaya, Ismet, et al.
Publicado: (2018)

New frontiers in focal therapy for prostate cancer: Prostate-specific membrane antigen positron emission tomography/magnetic resonance imaging
por: Manfredi, Celeste, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vte23af94i4o7eugghh96l35lj